Show simple item record

dc.contributor.authorGodman, Brian
dc.contributor.authorEgwuenu, Abiodun
dc.contributor.authorNcube, Nondumiso B. Q.
dc.date.accessioned2022-09-13T10:40:08Z
dc.date.available2022-09-13T10:40:08Z
dc.date.issued2022
dc.identifier.citationGodman, B. et al. (2022). Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future. Expert Opinion on Drug Safety, 21(8), 1089-1111. 10.1080/14740338.2022.2106368en_US
dc.identifier.issn1744-764X
dc.identifier.urihttps://doi.org/10.1080/14740338.2022.2106368
dc.identifier.urihttp://hdl.handle.net/10566/7878
dc.description.abstractAntimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting. Areas covered: Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature.en_US
dc.language.isoenen_US
dc.publisherTaylor and Francis Groupen_US
dc.subjectAntimicrobial resistanceen_US
dc.subjectNational action planen_US
dc.subjectPublic healthen_US
dc.subjectMortalityen_US
dc.subjectSub-Saharan Africaen_US
dc.titleTackling antimicrobial resistance across Sub-Saharan Africa: Current challenges and implications for the futureen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record